Dipal Doshi Entrada Therapeutics, Inc. (TRDA) insider trading activity

TRDA Quotes by TradingView

Dipal Doshi is CEO of Entrada Therapeutics, Inc.. Currently has a direct ownership of 325,753 shares of TRDA, which is worth approximately $5.73 Million. The most recent transaction as insider was on Sep 05, 2024, when has been sold 826 shares (Common Stock) at a price of $15.13 per share, resulting in proceeds of $12,497. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 326K
0% 3M change
32.81% 12M change
Total Value Held $5.73 Million

Dipal Doshi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 05 2024
SELL
Payment of exercise price or tax liability
$12,497 $15.13 p/Share
826 Reduced 0.25%
325,753 Common Stock
Sep 04 2024
SELL
Payment of exercise price or tax liability
$73,152 $15.42 p/Share
4,744 Reduced 1.43%
326,579 Common Stock
Sep 03 2024
SELL
Payment of exercise price or tax liability
$52,953 $16.8 p/Share
3,152 Reduced 0.94%
331,323 Common Stock
Jul 15 2024
SELL
Open market or private sale
$28,495 $17.81 p/Share
1,600 Reduced 0.48%
334,475 Common Stock
Jul 12 2024
SELL
Open market or private sale
$5,400 $18.0 p/Share
300 Reduced 0.09%
336,075 Common Stock
Jun 13 2024
SELL
Open market or private sale
$16,170 $16.17 p/Share
1,000 Reduced 0.3%
336,375 Common Stock
May 17 2024
SELL
Open market or private sale
$18,132 $15.11 p/Share
1,200 Reduced 0.35%
337,375 Common Stock
May 16 2024
SELL
Open market or private sale
$27,000 $15.0 p/Share
1,800 Reduced 0.53%
338,575 Common Stock
Mar 05 2024
SELL
Payment of exercise price or tax liability
$62,001 $12.28 p/Share
5,049 Reduced 1.46%
340,375 Common Stock
Mar 04 2024
SELL
Payment of exercise price or tax liability
$32,959 $12.9 p/Share
2,555 Reduced 0.73%
345,424 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
104,700 Added 23.13%
347,979 Common Stock
Feb 15 2024
SELL
Open market or private sale
$15,000 $15.0 p/Share
1,000 Reduced 0.41%
243,279 Common Stock
Jan 16 2024
SELL
Open market or private sale
$15,990 $15.99 p/Share
1,000 Reduced 0.41%
244,279 Common Stock
Dec 20 2023
SELL
Open market or private sale
$15,000 $15.0 p/Share
1,000 Reduced 0.41%
245,279 Common Stock
Nov 13 2023
SELL
Open market or private sale
$16,230 $16.23 p/Share
1,000 Reduced 0.4%
246,279 Common Stock
Oct 17 2023
SELL
Open market or private sale
$15,000 $15.0 p/Share
1,000 Reduced 0.4%
247,279 Common Stock
Sep 13 2023
SELL
Open market or private sale
$15,000 $15.0 p/Share
1,000 Reduced 0.4%
248,279 Common Stock
Sep 05 2023
SELL
Payment of exercise price or tax liability
$20,822 $14.46 p/Share
1,440 Reduced 0.57%
249,279 Common Stock
Sep 01 2023
BUY
Grant, award, or other acquisition
-
49,650 Added 16.53%
250,719 Common Stock
Aug 14 2023
SELL
Open market or private sale
$15,670 $15.67 p/Share
1,000 Reduced 0.49%
201,069 Common Stock
Apr 27 2023
SELL
Open market or private sale
$27,420 $13.71 p/Share
2,000 Reduced 0.98%
202,069 Common Stock
Apr 17 2023
SELL
Open market or private sale
$37,676 $18.01 p/Share
2,092 Reduced 1.01%
204,069 Common Stock
Mar 27 2023
SELL
Open market or private sale
$30,140 $15.07 p/Share
2,000 Reduced 0.78%
255,811 Common Stock
Mar 02 2023
SELL
Payment of exercise price or tax liability
$38,558 $11.6 p/Share
3,324 Reduced 1.27%
257,811 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
99,300 Added 27.55%
261,135 Common Stock
DD

Dipal Doshi

CEO
Boston, MA

Track Institutional and Insider Activities on TRDA

Follow Entrada Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TRDA shares.

Notify only if

Insider Trading

Get notified when an Entrada Therapeutics, Inc. insider buys or sells TRDA shares.

Notify only if

News

Receive news related to Entrada Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TRDA